About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in California | 676 Studies

Clinical Trials Pancreatic CancerCalifornia

Pancreatic Cancer Clinical Trials in California

Find 676 clinical trials for pancreatic cancer near California. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 301-320 of 676 trials

UnknownIMX-110 in Patients With Advanced Solid TumorsPhase 1 is an open-label, multi-center dose escalation/dose expansion study designed to assess the safety, tolerability and pharmacokinetics (PK) for the recommended phase 2 dose…NCT03382340·Santa Monica, California and 1 other CompletedMEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.The purpose of this study is to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI9447 Alone and in Combination with MEDI4736 in…NCT02503774·La Jolla, California and 17 others RecruitingA Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerThis study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic CancerNCT07644559·Los Angeles, California and 28 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingComparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET TrialThis phase II trial compares the effect of combination therapy with capecitabine and temozolomide to lutetium Lu 177 dotatate for the treatment of pancreatic neuroendocrine tumors…NCT05247905·Fairbanks, Alaska and 170 others

Active not recruitingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsThis is an open-label, dose-exploration and expansion study to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of…NCT05585320·Scottsdale, Arizona and 19 others

TerminatedHigh or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryThis randomized phase II trial studies how well high or standard intensity radiochemotherapy after gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticle…NCT01921751·Oakland, California and 45 others

CompletedPhase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic AdenocarcinomaThis multi-institutional trial aims to evaluate the potential benefit and side effects of adding fractionated stereotactic body radiotherapy/surgery (SBRT) before and after…NCT01146054·Stanford, California and 2 others

Not yet recruitingThe Canopy Cancer Collective Clinical Registry ProtocolThe Canopy Cancer Collective Clinical Registry Protocol Non-Interventional Data and Sample Collection Registry Protocol Number of study sites 15 Study Design - Observational…NCT07605702·San Diego, California and 9 others

CompletedSafety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsTest the hypothesis that itacitinib (INCB039110) can be administered safely in combination with gemcitabine and nab-paclitaxel in subjects with advanced or metastatic cancer.NCT01858883·Scottsdale, Arizona and 7 others

CompletedA Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic CancerThe purpose of this study is to determine whether the combination of MM-141 plus nab-paclitaxel and gemcitabine is more effective than nab-paclitaxel and gemcitabine alone based…NCT02399137·Gilbert, Arizona and 65 others

TerminatedNutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic CancerThere are few well-designed studies evaluating the effect of nutrition support in patients with cancer cachexia.NCT02681601·Los Angeles, California

CompletedRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaRATIONALE: Monoclonal antibodies, such as RAV12, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00101972·Santa Monica, California and 4 others

TerminatedStudy of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginThis study will assess the effectiveness and safety of pasireotide long-acting release in patients who have rare tumors of neuroendocrine origin.NCT00958841·Los Angeles, California and 41 others

Active not recruitingLenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic CancerThis phase II trial studies the effects of lenvatinib and pembrolizumab maintenance therapy in treating patients with pancreatic cancer that has spread to other places in the body…NCT04887805·Duarte, California

CompletedLEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)The purpose of this signal seeking study was to determine whether treatment with LEE011 demonstrates sufficient efficacy in CDK4/6 pathway activated solid tumors and/or…NCT02187783·Birmingham, Alabama and 60 others

Active not recruitingTesting Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsThis phase III trial studies cabozantinib to see how well it works compared with placebo in treating patients with neuroendocrine or carcinoid tumors that may have spread from…NCT03375320·Anchorage, Alaska and 431 others

RecruitingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsThis phase I trial studies the side effects and best dose of modified immune cells (IL13Ralpha2 CAR T cells) after a chemotherapy conditioning regimen for the treatment of…NCT04119024·Duarte, California and 2 others

RecruitingStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsThis is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 (givastomig) in subjects with advanced or…NCT04900818·Orange, California and 20 others

CompletedA SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic CancerChemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission.NCT03331562·Scottsdale, Arizona and 5 others

TerminatedA Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid TumorsThe purpose of this study is to find a safe, tolerable, and efficacious dose of BMS-986466 when given orally, in combination with adagrasib with or without cetuximab in…NCT06024174·Los Angeles, California and 8 others

PreviousPage 16 of 34Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia